tegafur and warfarin
tegafur has been researched along with warfarin in 21 studies
Research
Studies (21)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (14.29) | 18.7374 |
1990's | 2 (9.52) | 18.2507 |
2000's | 5 (23.81) | 29.6817 |
2010's | 11 (52.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hirose, S; Kito, M; Takeshima, S; Urakami, K; Yoshida, S | 1 |
Inoue, H; Ogawa, J; Shohtsu, A | 1 |
Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A; Tsurumi, T | 1 |
Inoue, H; Kawada, S; Koide, S; Ogawa, J; Shohtsu, A | 1 |
Miyazawa, N; Uematsu, T; Wada, K | 1 |
Kaniwa, N; Murayama, N; Nakajima, Y; Ohno, Y; Ozawa, S; Sai, K; Sawada , J | 1 |
Ariyoshi, N; Daigo, S; Fujieda, M; Ikeda, K; Kamataki, T; Koizumi, W; Nagayama, S; Nishioka, Y; Saigenji, K; Takahashi, Y; Tanabe, S; Yamazaki, H | 1 |
Ishii, E; Kondo, M; Munakata, M; Sakata, Y; Shitara, K; Wada, R | 1 |
Anami, S; Azuma, J; Fujii, C; Fujino, M; Furukawa, H; Matsumura, T; Nishiguchi, T; Ohno, M; Ohsato, H; Tsuge, M; Yamamoto, A; Yasui, Y | 1 |
Kubota, Y; Marutaka, M; Orita, Y; Yoshida, R | 1 |
Chatani, T; Doi, Y; Fukuda, H; Horiki, M; Iwasaki, R; Kashihara, T; Kitada, M; Kondo, S; Murayama, Y; Okuno, M; Sano, I | 1 |
Egashira, N; Kubota, T; Nonaka, T; Oishi, R; Sonoda, M; Takada, A; Watanabe, H; Yamada, T; Yano, T | 1 |
Hori, S; Kondo, G; Maeda, T; Miki, A; Satoh, H; Sawada, Y; Yamamuro, F | 1 |
Ito, S; Nakamura, Y; Noumi, T; Sasaki, Y | 1 |
Chiba, M; Ishii, Y; Yamada, H; Yamamiya, I; Yoshisue, K | 1 |
Itoh, H; Jinbu, Y; Kusama, M; Miyagi, N; Nakai, Y; Noguchi, T; Shinozaki, Y; Sugiyama, T; Tsuchiya, Y; Watanabe, H | 1 |
Hirashiki, A; Hirooka, Y; Murohara, T; Yamada, K; Yamamura, K; Yano, K | 1 |
Fuse, N; Ikegawa, K; Nomura, H; Saito, S; Suzuki, S; Yamamoto, K | 1 |
Doki, Y; Haraguchi, N; Hata, T; Kudo, T; Mizushima, T; Mori, M; Nishimura, J; Sakai, D; Satoh, T; Takahashi, H; Yamamoto, H | 1 |
Ikegawa, K; Saito, S; Suzuki, S; Yamamoto, K | 1 |
Reviews
1 review(s) available for tegafur and warfarin
Article | Year |
---|---|
[Reinforcement of warfarin action in a patient administered S-1].
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Cardiomyopathy, Hypertrophic; Cerebral Infarction; Drug Combinations; Drug Interactions; Humans; Male; Mouth Neoplasms; Neoplasms, Squamous Cell; Oxonic Acid; Tachycardia, Ventricular; Tegafur; Warfarin | 2015 |
Other Studies
20 other study(ies) available for tegafur and warfarin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
High-performance liquid chromatography with chemiluminescence detection of serum levels of pre-column derivatized fluoropyrimidine compounds.
Topics: Chromatography, High Pressure Liquid; Coumarins; Floxuridine; Fluorine; Fluorouracil; Humans; Molecular Structure; Pyrimidines; Tegafur; Umbelliferones; Uridine | 1990 |
[Interactions between UFT and anticoagulants].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase (NAD+); Drug Interactions; Drug Synergism; Humans; Lung Neoplasms; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Tegafur; Uracil; Warfarin | 1987 |
Interactions between UFT and anticoagulants in lung cancer patients.
Topics: Aged; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Drug Interactions; Drug Therapy, Combination; Humans; Lung Neoplasms; Postoperative Care; Tegafur; Ticlopidine; Uracil; Warfarin | 1988 |
[Experimental and clinical study of interactions between fluorinated pyrimidine derivatives and anticoagulants].
Topics: Animals; Anticoagulants; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Fluorouracil; Humans; Lung Neoplasms; Neoplasm Transplantation; Pyrimidines; Rats; Rats, Inbred Strains; Tegafur; Ticlopidine; Uracil; Warfarin | 1988 |
1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) determined in rat hair as an index of drug exposure.
Topics: Animals; Coumarins; Drug Stability; Fluorescence; Fluorescent Dyes; Hair; Hydrogen-Ion Concentration; Male; Rats; Rats, Inbred Strains; Tegafur | 1993 |
Expression of CYP2A6 in tumor cells augments cellular sensitivity to tegafur.
Topics: Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Cell Division; Colonic Neoplasms; Coumarins; Cytochrome P-450 CYP2A6; Cytochrome P-450 Enzyme System; Fluorouracil; Gene Expression; Humans; Hydroxylation; Microsomes; Mixed Function Oxygenases; Tegafur; Transfection; Tumor Cells, Cultured | 2001 |
A novel mutant allele of the CYP2A6 gene (CYP2A6*11 ) found in a cancer patient who showed poor metabolic phenotype towards tegafur.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Coumarins; Cytochrome P-450 CYP2A6; DNA Primers; DNA, Neoplasm; Drug Combinations; Escherichia coli; Genotype; Humans; Kinetics; Middle Aged; Mixed Function Oxygenases; Mutagenesis, Site-Directed; Oxonic Acid; Polymerase Chain Reaction; Polymorphism, Genetic; Pyridines; Recombinant Proteins; Stomach Neoplasms; Tegafur; Transfection | 2002 |
[A case of duodenal carcinoma with massive peritoneal carcinomatosis complicating a pulmonary embolism].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Drug Therapy, Combination; Duodenal Neoplasms; Female; Heparin; Humans; Middle Aged; Oxonic Acid; Peritoneal Neoplasms; Pulmonary Embolism; Quality of Life; Taxoids; Tegafur; Warfarin | 2006 |
[A case of bleeding tendency due to warfarin in a patient treated with chemotherapy by S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenal Neoplasms; Hemorrhage; Humans; Male; Oxonic Acid; Stereoisomerism; Tegafur; Thrombosis; Treatment Failure; Warfarin | 2008 |
[Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case].
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Cerebral Infarction; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Humans; Male; Oxonic Acid; Stomach Neoplasms; Tegafur; Warfarin | 2009 |
[A case of type 4 gastric cancer with peritoneal dissemination complicating venous thromboembolism treated effectively by combination of S-1 and warfarin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Combined Modality Therapy; Drug Combinations; Female; Gastroscopy; Humans; Middle Aged; Neoplasm Staging; Oxonic Acid; Peritoneal Neoplasms; Quality of Life; Stomach Neoplasms; Tegafur; Tomography, X-Ray Computed; Venous Thromboembolism; Warfarin | 2010 |
Timing of expression of blood coagulation abnormality in patients treated with warfarin and s-1 concomitantly.
Topics: Aged; Aged, 80 and over; Anticoagulants; Blood Coagulation Disorders; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Monitoring, Physiologic; Oxonic Acid; Retrospective Studies; Tegafur; Time Factors; Warfarin | 2010 |
Individual differences in prothrombin time-international normalized ratio variation following coadministration of the anticancer agents S-1 and warfarin: 3 case reports.
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Drug Combinations; Drug Interactions; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oxonic Acid; Prothrombin Time; Tegafur; Warfarin | 2011 |
Acute aortic thrombosis during cisplatin based chemotherapy for gastric cancer.
Topics: Acute Disease; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Aortic Diseases; Aortography; Arterial Occlusive Diseases; Carcinoma, Signet Ring Cell; Cisplatin; Dexamethasone; Drug Combinations; Heparin; Humans; Oxonic Acid; Stomach Neoplasms; Tegafur; Thrombosis; Tomography, X-Ray Computed; Warfarin | 2013 |
Effect of CYP2A6 genetic polymorphism on the metabolic conversion of tegafur to 5-fluorouracil and its enantioselectivity.
Topics: Cell Line; Coumarins; Cytochrome P-450 CYP2A6; DNA, Complementary; Escherichia coli; Fluorouracil; Humans; Microsomes, Liver; Nicotine; Polymorphism, Genetic; Sf9 Cells; Tegafur | 2014 |
A Successful Case of a Patient Undergoing Warfarin and S-1 Therapy Using Internet-based Control of Home-measured PT-INR.
Topics: Cholangiocarcinoma; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; International Normalized Ratio; Internet; Male; Middle Aged; Monitoring, Physiologic; Oxonic Acid; Prothrombin Time; Tegafur; Warfarin | 2015 |
[Evaluation of Drug Interaction between S-1 and Warfarin].
Topics: Aged; Aged, 80 and over; Anticoagulants; Antimetabolites, Antineoplastic; Drug Combinations; Drug Interactions; Female; Humans; Male; Middle Aged; Neoplasms; Oxonic Acid; Prothrombin Time; Retrospective Studies; Tegafur; Warfarin | 2016 |
Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer.
Topics: Anticoagulants; Antimetabolites, Antineoplastic; Capecitabine; Drug Combinations; Drug Interactions; Female; Gastrointestinal Neoplasms; Humans; International Normalized Ratio; Male; Middle Aged; Oxonic Acid; Prothrombin Time; Retrospective Studies; Tegafur; Warfarin | 2016 |
Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antimetabolites, Antineoplastic; Drug Combinations; Drug Interactions; Female; Humans; International Normalized Ratio; Male; Middle Aged; Oxonic Acid; Prothrombin Time; Retrospective Studies; Stomach Neoplasms; Tegafur; Warfarin | 2016 |